Oncocyte Reports Third Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St set for tepid open as oil prices fall, Treasury yields rise
- Oil prices edge lower on easing fears over Saudi supply disruption
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
OncoCyte Corporation (OCX) Tops Q3 EPS by 3c
November 10, 2022 4:37 PM ESTOncoCyte Corporation (NASDAQ: OCX) reported Q3 EPS of ($0.08), $0.03 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $1 million versus the consensus estimate of $1.65 million.
For earnings history and earnings-related data on OncoCyte Corporation (OCX) click here.
... More